Cyclophosphamide (cyclophosphamide): Reviews and patient testimonials

Cyclophosphamide 1000 mg Powder for Solution for Injection or Infusion

Cyclophosphamide may be used alone or in combination with other chemotherapeutic agents, depending on the indication. Cyclophosphamide is indicated in the treatment of:

• Chronic Lymphocytic Leukemia (CLL)

• Acute Lymphocytic Leukemia (ALL)

• As conditioning for a bone marrow transplantation, in the treatment of Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia and Acute Myelogenous Leukemia, in combination with whole body irradiation or busulfan.

• Hodgkin's lymphoma, Non-Hodgkin's lymphoma and Multiple Myeloma.

• Metastatic ovarian, and breast, carcinoma,

• Adjuvant treatment of breast carcinoma

• Ewing's sarcoma

• Small cell lung cancer

• Advanced or metastatic neuroblastoma,

• Life-threatening autoimmune diseases: severe progressive forms of lupus nephritis and Wegener's granulomatosis.

Cyclophosphamide 2000 mg Powder for Solution for Injection or Infusion

Cyclophosphamide may be used alone or in combination with other chemotherapeutic agents, depending on the indication. Cyclophosphamide is indicated in the treatment of:

• Chronic Lymphocytic Leukemia (CLL)

• Acute Lymphocytic Leukemia (ALL)

• As conditioning for a bone marrow transplantation, in the treatment of Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia and Acute Myelogenous Leukemia, in combination with whole body irradiation or busulfan

• Hodgkin's lymphoma, Non-Hodgkin's lymphoma and Multiple Myeloma.

• Metastatic ovarian, and breast, carcinoma

• Adjuvant treatment of breast carcinoma

• Ewing's sarcoma

• Small cell lung cancer

• Advanced or metastatic neuroblastoma

• Life-threatening autoimmune diseases: severe progressive forms of lupus nephritis and Wegener's granulomatosis

Cyclophosphamide 500 mg Powder for Solution for Injection or Infusion

Cyclophosphamide may be used alone or in combination with other chemotherapeutic agents, depending on the indication. Cyclophosphamide is indicated in the treatment of:

• Chronic Lymphocytic Leukemia (CLL)

• Acute Lymphocytic Leukemia (ALL)

• As conditioning for a bone marrow transplantation, in the treatment of Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia and Acute Myelogenous Leukemia, in combination with whole body irradiation or busulfan.

• Hodgkin's lymphoma, Non-Hodgkin's lymphoma and Multiple Myeloma

• Metastatic ovarian, and breast, carcinoma

• Adjuvant treatment of breast carcinoma

• Ewing's sarcoma

• Small cell lung cancer

• Advanced or metastatic neuroblastoma,

• Life-threatening autoimmune diseases: severe progressive forms of lupus nephritis and Wegener's granulomatosis.

Cyclophosphamide Injection 1 g

Cyclophosphamide is a cytotoxic drug for the treatment of malignant disease in adults and children. As a single agent, it has successfully produced an objective remission in a wide range of malignant conditions. Cyclophosphamide is also frequently used in combination with other cytotoxic drugs, radiotherapy or surgery.

Cyclophosphamide Injection 500 mg

Cyclophosphamide is a cytotoxic drug for the treatment of malignant disease in adults and children. As a single agent, it has successfully produced an objective remission in a wide range of malignant conditions. Cyclophosphamide is also frequently used in combination with other cytotoxic drugs, radiotherapy or surgery.

Cyclophosphamide Tablets 50 mg

Cyclophosphamide is a cytotoxic drug for the treatment of malignant disease in adults and children. As a single agent, it has successfully produced an objective remission in a wide range of malignant conditions. Cyclophosphamide is also frequently used in combination with other cytotoxic drugs, radiotherapy or surgery.

Route of administration: Injectable, Oral
Molecule: cyclophosphamide